Hodgkin Disease Current Events | Hodgkin Disease News
|
|
|
Sort By:
Page Views | Date |
Delaying Chemotherapy Could Be Best Treatment Option For Certain Type Of Non-hodgkin Lymphoma (p 516)
Delaying chemotherapy until symptoms develop for patients with asymptomatic advanced low-grade non-Hodgkin lymphoma is confirmed as an appropriate strategy authors of a UK study in this week's issue of THE LANCET. Chemotherapy (single or aggressive combination therapy) does not cure advanced stage low-grade non-Hodgkin lymphomas, even when... view more... (2003-08-13)
DNA differences may influence risk of Hodgkin disease
A new analysis has found that certain variations in genes that repair DNA can affect a person's risk of developing Hodgkin disease. view more (2009-03-09)
Model predicts risk of breast cancer for young women treated for Hodgkin lymphoma
Young women who are treated for Hodgkin lymphoma with chest radiation therapy have a high cumulative absolute risk of developing breast cancer later in life. view more (2005-10-05)
USC researchers find new clues to risk of Hodgkin lymphoma
A long-term study of twins has led University of Southern California (USC) researchers to find potential links between Hodgkin lymphoma and levels of an immune response protein (interleukin-12). view more (2008-04-02)
Study analyzes heart attack mortality risk associated with Hodgkin disease treatments
Doctors have long known that patients treated for Hodgkin disease are at an increased risk for heart attacks. view more (2007-02-07)
Jefferson scientists studying the effects of high-dose vitamin C on non-Hodgkin lymphoma patients
Scientists at Thomas Jefferson University Hospital and Jefferson's Kimmel Cancer Center have received approval for a first-of-its kind study on the effect high dose vitamin C has on non-Hodgkin lymphoma patients. view more (2008-01-03)
Hodgkin disease survivors face higher risk for stroke later in life
Patients surviving childhood Hodgkin disease suffer strokes later in life at rates about four times that of the general population, UT Southwestern Medical Center researchers have found. view more (2005-10-14)
Work of Nobel-prize winning scientist Dorothy Hodgkin to be Celebrated with a Landmark Event at Oxford University
The work of the Nobel-prize winning crystallographer, Dorothy Hodgkin (1910-1994), which led to the synthesis of penicillin, vitamin B12 and insulin will be honoured by the Royal Society of Chemistry (RSC) at the University of Oxford on Monday 14 May 2001 through the designation of a National Historical Chemical Landmark. Dorothy Crowfoot Hodgkin... view more... (2001-05-10)
Hodgkin lymphoma -- new characteristics discovered
Researchers are still discovering new characteristics of Hodgkin lymphoma, a common form of cancer of the lymphatic system. The malignant cells are derived from white blood cells (B cells), but have lost a considerable part of the B cell-specific gene expression pattern. view more (2008-10-09)
Cell division find prompts overhaul of immune response modelling
Research at the Walter and Eliza Hall Institute into the mechanics of how two types of white blood cells grow and die is fundamentally changing the development of computer models that are used to predict how immune system cells respond to a pathogenic threat. view more (2009-07-21)
Women face high risk of developing breast cancer following radiotherapy for Hodgkin’s Disease
Women who have received radiotherapy for Hodgkin’s Disease have a three times higher relative risk of developing breast cancer than women from the general population, Professor Dietlind Wahner-Roedler told the 3rd European Breast Cancer Conference today (Saturday 23 March). If the women were younger than 30 when they received the treatment... view more... (2002-03-21)
Hepatitis C increases risk of non-Hodgkin lymphoma
Hepatitis C infection is associated with an increased risk of non-Hodgkin lymphoma (malignancy involving lymphatic tissue) of 20 percent to 30 percent, and a three-fold increase in the risk of another type of lymphoma, according to a study in the May 9 issue of JAMA. view more (2007-05-09)
Promising treatment target found in Hodgkin lymphoma
Dana-Farber Cancer Institute scientists have identified a protein that prevents the body's immune system from recognizing and attacking Hodgkin lymphoma cells. view more (2007-07-31)
Cost control measures limit patient and physician choice in psychotropic medications
A new Brandeis University study published online in Clinical Therapeutics suggests that private health plans increasingly rely on escalating copayments to manage drug costs, as opposed to administrative controls. view more (2007-03-02)
Quantitative PET Imaging Finds Early Determination of Effectiveness of Cancer Treatment
With positron emission tomography (PET) imaging, seeing is believing: Evaluating a patient's response to chemotherapy for non-Hodgkin lymphoma (NHL) typically involves visual interpretation of scans of cancer tumors. view more (2007-10-24)
The Meaning Of Life - On The Side Of A Building
An innovative partnership between art and science is being forged at a landmark five-storey development at one of Bristol`s most prominent city-centre locations. Its influence on the public understanding of science and on the integration of art into buildings could be far-reaching. Five large, arched windows at the Dorothy Hodgkin Building, a new... view more... (2002-08-28)
Chemotherapy can be more toxic to brain cells than to cancer cells and may cause brain damage
Drugs used to treat cancer may damage normal, healthy brain cells more than the cancer cells they are meant to target. view more (2006-11-30)
Early Detection Of Coeliac Disease Essential To Prevent Excess Deaths (p 356)
Death rates for people who have the intestinal disorder coeliac disease are twice that of the general population, conclude authors of a prospective study in this week's issue of THE LANCET. Early disease diagnosis is essential to prevent additional mortality. Coeliac disease is a disorder in which the small intestine is abnormally sensitive to... view more... (2001-08-01)
Do patients at risk for B-cell malignancy need antiviral treatment?
Some studies have shown that a relationship of hepatitis C (HCV) infection with type II mixed cryoglobulinemia exists. However the precise mechanism remains unclear. view more (2009-04-15)
Intense chemotherapy wards off recurrence in half of mantle cell lymphoma patients after seven years
More than half of younger mantle cell lymphoma patients who received an intensive regimen of chemotherapy as frontline treatment remain in remission seven years later, researchers at The University of Texas M. D. Anderson Cancer Center report today at the 50th annual meeting of the American Society of Hematology. view more (2008-12-10)
|
|
|
|
Sort By:
Page Views | Date |
|
